Showing results (1-10 of 60) with videos related to
Sort By:
Pageof 6
Arteriosclerosis, Thrombosis, and Vascular Biology|November 10, 2001
Inclusion of the E3 region in an adenoviral vector decreases inflammation and neointima formation after arterial gene transferS Wen, R M Driscoll, D B Schneider, et al.Human Gene Therapy|May 15, 1998
Adenoviral gene transfer in arteries of hypercholesterolemic nonhuman primatesD B Schneider, C A Fly, D A Dichek, et al.Journal of Vascular Surgery|March 9, 1999
Adventitial delivery minimizes the proinflammatory effects of adenoviral vectorsD B Schneider, A B Sassani, G Vassalli, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|June 10, 2000
Second-generation adenoviral vectors do not prevent rapid loss of transgene expression and vector DNA from the arterial wallS Wen, D B Schneider, R M Driscoll, et al.Molecular Biology & Medicine|April 1, 1991
Retroviral vector-mediated gene transfer into endothelial cellsD A DichekNature Medicine|July 1, 1997
Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destructionS M Kang, D B Schneider, Z Lin, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|February 17, 2000
Expression of Fas ligand in arteries of hypercholesterolemic rabbits accelerates atherosclerotic lesion formationD B Schneider, G Vassalli, S Wen, et al.Transplantation|June 1, 2000
A non-cleavable mutant of Fas ligand does not prevent neutrophilic destruction of islet transplantsS M Kang, D Braat, D B Schneider, et al.Pageof 6